Fernando Rogério Pavan
CV Lattes
GoogleMyCitations
ResearcherID
ORCID
Universidade Estadual Paulista (UNESP). Campus de Araraquara. Faculdade de Ciências Farmacêuticas (FCFAR) (Institutional affiliation for the last research proposal) Birthplace: Brazil
graduation at Ciências Biológicas Modalidade Médica from Centro Universitário Barão de Mauá (2004), master's at Pharmacy from Universidade Estadual Paulista Júlio de Mesquita Filho (2009) and doctorate at Pharmacy from Universidade Estadual Paulista Júlio de Mesquita Filho (2011). Has experience in Microbiology, acting on the following subjects: mycobacterium tuberculosis, maba, new drugs, anti-m. tuberculosis activity and novos fármacos. (Source: Lattes Curriculum)
- Development and search of new antimicrobials against tuberculosis: from screening to pre-clinical studies in vivo, AP.R
Abstract
In the last report of the World Health Organization 12 bacteria with high incidence of resistance and more Mycobacterium tuberculosis were determinant in the urgency in research and development (R&D) of new antimicrobials. In 2016 there were 10.4 million new cases of tuberculosis (TB) in the world, of which only 6 million were diagnosed and reported. Resistance to antimicrobials against...
- Research potential against tuberculosis of a new class of furoxan compounds and nanostructured compounds of the ruthenium(II) and copper (II), AP.JP
Abstract
Mycobacterium tuberculosis (MTB), agent of tuberculosis (TB), is responsible for the death of around 2-3 million people annually and a global economic toll of ~$12 billion each year. For more than 50 years after the introduction of rifampicin (RMP) in 1960, no new drug had been developed against TB. All the need of a new molecule, led to quickly TMC-207 approval by the FDA (Food and Dru...
- In search of the mechanism of action of the tris-(1,10-phenanthroline)iron (II) complex and its possible effects against Mycobacterium tuberculosis, BP.MS
Abstract
Considering the accelerated pace of new cases emergence of tuberculosis (TB), about 10 million per year, the high rates of resistance to main classes of antimicrobials, and taking into account that TB occupies the first place in the ranking of causes of death by an infectious agent, becomes evident the need to control and combat this disease which poses a serious threat to global public...
- Efflux pumps as a possible mechanism of resistance to 2nd line drugs: phenotypic and genotypic evaluation in resistant clinical isolates of Mycobacterium Tuberculosis, BP.IC
Abstract
On the planet, the Tuberculosis (TB) mortality rate decreased by 47% since 1990 to 2015, however, an estimated 1.3 million TB deaths by 2016. This means that, even as the mortality rate decreases over the years, it is still considered one of the 10 leading causes of death worldwide, and an important contributing factor is the emergence of multidrug resistant strains (MDR- TB) and / or e...
- Nanostructured lipid system as carrier for benzofuroxanic derivative applicable in the study against Mycobacterium Tuberculosis, BP.IC
Abstract
Tuberculosis is the infectious disease that causes most deaths worldwide and Brazil is one of the 20 countries that register more incident cases. The emergence of multi-drug resistant strains has created a scenario with more complicated treatments and even incurable cases, and reports of resistance to new drugs that are still under clinical trials have already been observed. Benzofuroxa...
(Only some records are available in English at this moment)
- Safety assessment of benzofuroxan derivatives with potential use in antitubercular therapy by toxicological and toxigenomic approaches, BP.PD
Abstract
Tuberculosis is a contagious disease caused by Mycobacterium tuberculosis, which mainly attacks lungs and other parts of the body like kidneys, eyes and bones. It is a disease of global incidence, infecting one third of the entire world population. With this, tuberculosis is currently responsible for the deaths of 1.7 million people a year; indices greater than those observed for any ot...
- Determination of the frequency of mutations of Mycobacterium tuberculosis against the compound tris-(1.10-phenanthroline)iron(II) and in vivo bioavailability studies, BP.IC
Abstract
Tuberculosis is a disease caused by Mycobacterium tuberculosis. According to World Health Organization, 10.4 million new cases of tuberculosis were estimated in 2015, of which 480,000 are multidrug-resistant. Compared with previous years, the increase in resistant infections is noteworthy, leading to the need for new drugs. As the object of this project we will study the tris-(1.10-phen...
- Study of the biological profile of tris-(1,10-phenanthroline) iron (II) complex and possible mechanisms of action against Mycobacterium tuberculosis, BP.MS
Abstract
Tuberculosis (TB) is an infectious disease and its principal causative agent is Mycobacterium tuberculosis. Although the disease has received advances that promote its control and treatment, TB is still responsible for about two million deaths annually, a rate higher than HIV. The high rates of disease occurrence are attributed in part to the emergence of multidrug resistant (MDR) and e...
(Only some records are available in English at this moment)
- Molecular toxicology testing of benzofuraxanes, BE.EP.PD
Abstract
Tuberculosis is a contagious disease caused by Mycobacterium tuberculosis, which mainly attacks lungs and other parts of the body such as kidneys, eyes and bones. It is a disease of global incidence, infecting one third of the entire world population. With this, tuberculosis is currently responsible for deaths of 1.7 million people per year; values higher than those observed for any oth...
- In vitro and in vivo studies of furoxan compounds: permeability, frequency of resistance, activity against resistance strains and in vivo efficacy, BE.EP.DR
Abstract
This project is associated to FAPESP doctoral fellowship process number 2014/11586-9, entitled: "Studies in vitro and in vivo of furoxan compounds with potential application for the treatment of tuberculosis". The work will be performed under supervisor of the Prof. Scott Gary Franzblau (Professor and Director) at the University of Illinois at Chicago (Institute for Tuberculosis Researc...
| 1 / 1 | Ongoing research grants |
| 1 / 1 | Completed research grants |
| 5 / 5 | Ongoing scholarships in Brazil |
| 10 / 9 | Completed scholarships in Brazil |
| 1 / 1 | Ongoing scholarships abroad |
| 1 / 1 | Completed scholarships abroad |
| 19 / 18 | All research grants and scholarships |
| Associated processes | |
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
| Publications | 40 |
| Citations | 702 |
| Cit./Article | 17.6 |
| Data from Web of Science | |
ELAINE S. COIMBRA; JULIANA A. SANTOS; LARISSA L. LIMA; PATRÍCIA A. MACHADO; DÉBORA L. CAMPOS; FERNANDO R. PAVAN; ADILSON D. SILVA. Synthesis, Antitubercular and Leishmanicidal Evaluation of Resveratrol Analogues. Journal of the Brazilian Chemical Society, v. 27, n. 12, p. 2161-2169, Dez. 2016. Web of Science Citations: 5. (13/14957-5)
POGGI, MARIANA; BARROSO, RAFAEL; COSTA-FILHO, ANTONIO JOSE; DE BARROS, HELOISA BARBOSA; PAVAN, FERNANDO; LEITE, CLARICE QUEICO; GAMBINO, DINORAH; HELVECIA TORRE, MARIA. New Isoniazid Complexes, Promising Agents Against Mycobacterium tuberculosis. Journal of the Mexican Chemical Society, v. 57, n. 3, p. 198-204, JUL-SEP 2013. Web of Science Citations: 13. (09/06499-1, 11/11593-7)
OLIVEIRA, CAROLINA G.; MAIA, PEDRO IVO DA S.; MIYATA, MARCELO; PAVAN, FERNANDO R.; LEITE, CLARICE Q. F.; DE ALMEIDA, EDUARDO TONON; DEFLON, VICTOR M.. Cobalt(III) Complexes with Thiosemicarbazones as Potential anti-Mycobacterium tuberculosis Agents. Journal of the Brazilian Chemical Society, v. 25, n. 10, p. 1848+, OCT 2014. Web of Science Citations: 13. (13/14957-5, 09/54011-8, 11/16380-1)
CALEFFI-FERRACIOLI, KATIANY R.; CARDOSO, ROSILENE F.; DE SOUZA, JOAO V. P.; MURASE, LETICIA S.; CANEZIN, PEDRO H.; SCODRO, REGIANE B. L.; SIQUEIRA, VERA L. D.; PAVAN, FERNANDO R.. Modulatory effects of verapamil in rifampicin activity against Mycobacterium tuberculosis. FUTURE MICROBIOLOGY, v. 14, n. 3, p. 185-194, FEB 2019. Web of Science Citations: 0. (13/14957-5)
FUMAGALLI, FERNANDO; GIL DE MELO, SHAIANI MARIA; RIBEIRO, CAMILA MARINGOLO; SOLCIA, MARIANA CRISTINA; PAVAN, FERNANDO ROGERIO; EMERY, FLAVIO DA SILVA. Exploiting the furo [2,3-b]pyridine core against multidrug-resistant Mycobacterium tuberculosis. Bioorganic & Medicinal Chemistry Letters, v. 29, n. 8, p. 974-977, APR 15 2019. Web of Science Citations: 0. (14/50265-3, 17/21146-4, 15/06588-5, 18/00163-0)
MCCARRON, PAURAIC; MCCANN, MALACHY; DEVEREUX, MICHAEL; KAVANAGH, KEVIN; SKERRY, CIARAN; KARAKOUSIS, PETROS C.; AOR, ANA C.; MELLO, THAIS P.; SANTOS, ANDRE L. S.; CAMPOS, DEBORA L.; et al. Unprecedented in Vitro Antitubercular Activitiy of Manganese(II) Complexes Containing 1,10-Phenanthroline and Dicarboxylate Ligands: Increased Activity, Superior Selectivity, and Lower Toxicity in Comparison to Their Copper(II) Analogs. FRONTIERS IN MICROBIOLOGY, v. 9, JUL 2 2018. Web of Science Citations: 1. (13/14957-5)
DA SILVA, PATRICIA BENTO; CAMPOS, DEBORA LEITE; RIBEIRO, CAMILA MARINGOLO; DA SILVA, ISABEL CRISTIANE; PAVAN, FERNANDO ROGERIO. New antimycobacterial agents in the pre-clinical phase or beyond: recent advances in patent literature (2001-2016). EXPERT OPINION ON THERAPEUTIC PATENTS, v. 27, n. 3, p. 269-282, MAR 2017. Web of Science Citations: 4. (13/14957-5)
DE GRANDIS, RONE APARECIDO; DA SILVA DOS SANTOS, PATRICK WELLINGTON; DE OLIVEIRA, KATIA MARA; TOMAZELA MACHADO, ANA RITA; AISSA, ALEXANDRE FERRO; BATISTA, ALZIR AZEVEDO; GREGGI ANTUNES, LUSANIA MARIA; PAVAN, FERNANDO ROGERIO. Novel lawsone-containing ruthenium(II) complexes: Synthesis, characterization and anticancer activity on 2D and 3D spheroid models of prostate cancer cells. BIOORGANIC CHEMISTRY, v. 85, p. 455-468, APR 2019. Web of Science Citations: 0. (16/16312-0, 16/22429-7, 18/00163-0)
DA SILVA, PATRICIA B.; DE FREITAS, EDUARDO SINESIO; SOLCIA, MARIANA CRISTINA; DE SOUZA, PAULA CAROLINA; DA SILVA, MONIZE MARTINS; BATISTA, ALZIR AZEVEDO; EISMANN, CARLOS E.; ROLISOLA, ANA MARTA C. M.; MENEGARIO, AMAURI A.; CARDOSO, ROSILENE FRESSATTI; et al. A Nanostructures Lipid System to Improve the Oral Bioavailability of Ruthenium(II) Complexes for the Treatment of Infections Caused by Mycobacterium tuberculosis. FRONTIERS IN MICROBIOLOGY, v. 9, DEC 6 2018. Web of Science Citations: 1. (13/14957-5, 13/09265-7)
DE SOUZA, PAULA C.; MAIA, PEDRO I. S.; DE BARROS, HELOISA B.; LEITE, CLARICE Q. F.; DEFLON, VICTOR M.; PAVAN, FERNANDO R.. Vanadium Complexes with Hydrazone or Thiosemicarbazone Ligands as Potential Anti-Mycobacterium tuberculosis Agents. CURRENT CLINICAL PHARMACOLOGY, v. 10, n. 1, p. 66-72, 2015. Web of Science Citations: 1. (13/14957-5, 14/11586-9, 09/54011-8)
DE CAMARGO, MARIANA S.; DE GRANDIS, RONE A.; DA SILVA, MONIZE M.; DA SILVA, PATRICIA B.; SANTONI, MARIANA M.; EISMANN, CARLOS E.; MENEGARIO, AMAURI A.; COMINETTI, MARCIA R.; ZANELLI, CLESLEI F.; PAVAN, FERNANDO R.; et al. Determination of in vitro absorption in Caco-2 monolayers of anticancer Ru(II)-based complexes acting as dual human topoisomerase and PARP inhibitors. BIOMETALS, v. 32, n. 1, p. 89-100, FEB 2019. Web of Science Citations: 2. (12/21529-7, 16/16312-0, 16/22429-7)
SANTOS, JEAN L.; YAMASAKI, PAULO R.; CHIN, CHUNG MAN; TAKASHI, CELIO H.; PAVAN, FERNANDO R.; LEITE, CLARICE Q. F.. Synthesis and in vitro anti Mycobacterium tuberculosis activity of a series of phthalimide derivatives. Bioorganic & Medicinal Chemistry, v. 17, n. 11, p. 3795-3799, JUN 1 2009. Web of Science Citations: 52. (08/10390-2, 07/56115-0)
DE PRINCE, KARINA ANDRADE; SORDI, RENATA; PAVAN, FERNANDO ROGERIO; BARRETO SANTOS, ADOLFO CARLOS; ARAUJO, ANGELA R.; LEITE, SERGIO R. A.; LEITE, CLARICE Q. F.. ANTI-MYCOBACTERIUM TUBERCULOSIS ACTIVITY OF FUNGUS PHOMOPSIS STIPATA. Brazilian Journal of Microbiology, v. 43, n. 1, p. 224-229, JAN-MAR 2012. Web of Science Citations: 3. (11/11593-7, 08/10390-2)
PAVAN, FERNANDO R.; DE CARVALHO, GUSTAVO SENRA G.; DA SILVA, ADILSON D.; LEITE, CLARICE Q. F.. Synthesis and Anti-Mycobacterium tuberculosis Evaluation of Aza-Stilbene Derivatives. SCIENTIFIC WORLD JOURNAL, v. 11, p. 1113-1119, 2011. Web of Science Citations: 7. (08/10390-2)
GAMBINO, DINORAH; FERNANDEZ, MARIANA; SANTOS, DIEGO; ETCHEVERRIA, GUSTAVO A.; PIRO, OSCAR E.; PAVAN, FERNANDO R.; LEITE, CLARICE Q. F.; TOMAZ, ISABEL; MARQUES, FERNANDA. Searching for gallium bioactive compounds: Gallium(III) complexes of tridentate salicylaldehyde semicarbazone derivatives. Polyhedron, v. 30, n. 7, p. 1360-1366, APR 27 2011. Web of Science Citations: 29. (08/10390-2)
PAVAN, FERNANDO R.; VON POELHSITZ, GUSTAVO; DO NASCIMENTO, FABIO B.; LEITE, SERGIO R. A.; BATISTA, ALZIR A.; DEFLON, VICTOR M.; SATO, DAISY N.; FRANZBLAU, SCOTT G.; LEITE, CLARICE Q. F.. Ruthenium (II) phosphine/picolinate complexes as antimycobacterial agents. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, v. 45, n. 2, p. 598-601, FEB 2010. Web of Science Citations: 35. (08/10390-2)
CORREIA, ISABEL; ADAO, PEDRO; ROY, SOMNATH; WAHBA, MOHAMED; MATOS, CRISTINA; MAURYA, MANNAR R.; MARQUES, FERNANDA; PAVAN, FERNANDO R.; LEITE, CLARICE Q. F.; AVECILLA, FERNANDO; et al. Hydroxyquinoline derived vanadium(IV and V) and copper(II) complexes as potential anti-tuberculosis and anti-tumor agents. Journal of Inorganic Biochemistry, v. 141, p. 83-93, DEC 2014. Web of Science Citations: 46. (13/14957-5)
DE FREITAS, EDUARDO SINESIO; DA SILVA, PATRICIA BENTO; CHORILLI, MARLUS; BATISTA, ALZIR AZEVEDO; LOPES, ERICA DE OLIVEIRA; DA SILVA, MONIZE MARTINS; FUJIMURA LEITE, CLARICE QUEICO; PAVAN, FERNANDO ROGERIO. Nanostructured Lipid Systems as a Strategy to Improve the in Vitro Cytotoxicity of Ruthenium(II) Compounds. Molecules, v. 19, n. 5, p. 5999-6008, MAY 2014. Web of Science Citations: 11. (13/14957-5, 13/09265-7)
MICHELETTI, ANA CAMILA; HONDA, NELI KIKA; PAVAN, FERNANDO R.; LEITE, CLARICE Q. F.; CEPA MATOS, MARIA DE FATIMA; PERDOMO, RENATA TRENTIN; BOGO, DANIELLE; ALCANTARA, GLAUCIA BRAZ; BEATRIZ, ADILSON. Increment of Antimycobaterial Activity on Lichexanthone Derivatives. Medicinal Chemistry, v. 9, n. 7, p. 904-910, NOV 2013. Web of Science Citations: 4. (09/06499-1, 08/10390-2)
PAIVA, ISABELA L.; DE CARVALHO, GUSTAVO S. G.; DA SILVA, ADILSON D.; CORBI, PEDRO P.; BERGAMINI, FERNANDO R. G.; FORMIGA, ANDRE L. B.; DINIZ, RENATA; DO CARMO, WEBERTON R.; LEITE, CLARICE Q. F.; PAVAN, FERNANDO R.; et al. Silver(I) complexes with symmetrical Schiff bases: Synthesis, structural characterization, DFT studies and antimycobacterial assays. Polyhedron, v. 62, p. 104-109, OCT 7 2013. Web of Science Citations: 12. (09/06499-1, 11/11593-7, 12/08230-2)
MONDELLI, MELINA; PAVAN, FERNANDO; DE SOUZA, PAULA C.; LEITE, CLARICE Q.; ELLENA, JAVIER; NASCIMENTO, OTACIRO R.; FACCHIN, GIANELLA; TORRE, MARIA H.. Study of a series of cobalt(II) sulfonamide complexes: Synthesis, spectroscopic characterization, and microbiological evaluation against M. tuberculosis. Crystal structure of [Co( sulfamethoxazole)(2)(H2O)(2)]center dot H2O. Journal of Molecular Structure, v. 1036, p. 180-187, MAR 27 2013. Web of Science Citations: 25. (09/06499-1, 11/11593-7)
MOREIRA, RAQUEL R. D.; MARTINS, GILMARCIO Z.; PIETRO, ROSEMEIRE C. L. R.; SATO, DAISY N.; PAVAN, FERNANDO R.; LEITE, SERGIO R. A.; VILEGAS, WAGNER; LEITE, CLARICE Q. F.. Paepalanthus spp: Antimycobacterial activity of extracts, methoxylated flavonoids and naphthopyranone fractions. REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY, v. 23, n. 2, p. 268-272, MAR-APR 2013. Web of Science Citations: 6. (11/11593-7, 08/10390-2)
SILVA, I. C.; POLAQUINI, C. R.; REGASINI, L. O.; FERREIRA, H.; PAVAN, F. R.. Evaluation of cytotoxic, apoptotic, mutagenic, and chemopreventive activities of semi-synthetic esters of gallic acid. Food and Chemical Toxicology, v. 105, p. 300-307, JUL 2017. Web of Science Citations: 16. (13/24449-7)
DOS SANTOS FERNANDES, GUILHERME FELIPE; DE SOUZA, PAULA CAROLINA; MORENO-VIGURI, ELSA; SANTIVANEZ-VELIZ, MERY; PAUCAR, ROCIO; PEREZ-SILANES, SILVIA; CHEGAEV, KONSTANTIN; GUGLIELMO, STEFANO; LAZZARATO, LORETTA; FRUTTERO, ROBERTA; et al. Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity. Journal of Medicinal Chemistry, v. 60, n. 20, p. 8647-8660, OCT 26 2017. Web of Science Citations: 8. (13/14957-5, 14/03920-6, 14/11586-9, 16/02860-5, 14/02240-1, 15/19531-1, 14/24811-0, 16/09502-7)
DA SILVA, PATRICIA BENTO; DE FREITAS, EDUARDO SINESIO; BERNEGOSSI, JESSICA; GONCALEZ, MAIRA LIMA; SATO, MARIANA RILLO; FUJIMURA LEITE, CLARICE QUEICO; PAVAN, FERNANDO ROGERIO; CHORILLI, MARIUS. Nanotechnology-Based Drug Delivery Systems for Treatment of Tuberculosis-A Review. JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, v. 12, n. 2, p. 241-260, FEB 2016. Web of Science Citations: 20. (13/14957-5, 12/19568-4, 13/09265-7)
DOS SANTOS FERNANDES, GUILHERME FELIPE; JORNADA, DANIELA HARTMANN; DE SOUZA, PAULA CAROLINA; CHIN, CHUNG MAN; PAVAN, FERNANDO ROGERIO; DOS SANTOS, JEAN LEANDRO. Current Advances in Antitubercular Drug Discovery: Potent Prototypes and New Targets. Current Medicinal Chemistry, v. 22, n. 27, p. 3133-3161, 2015. Web of Science Citations: 7. (13/14957-5, 14/24811-0, 14/02240-1)
OLIVEIRA, CAROLINA G.; MAIA, PEDRO IVO DA S.; SOUZA, PAULA C.; PAVAN, FERNANDO R.; LEITE, CLARICE Q. F.; VIANA, ROMMEL B.; BATISTA, ALZIR A.; NASCIMENTO, OTACIRO R.; DEFLON, VICTOR M.. Manganese(II) complexes with thiosemicarbazones as potential anti-Mycobacterium tuberculosis agents. Journal of Inorganic Biochemistry, v. 132, n. SI, p. 21-29, MAR 2014. Web of Science Citations: 16. (11/11593-7, 09/54011-8, 11/16380-1)
DOS SANTOS FERNANDES, GUILHERME FELIPE; DE SOUZA, PAULA CAROLINA; MARINO, LEONARDO BIANCOLINO; CHEGAEV, KONSTANTIN; GUGLIELMO, STEFANO; LAZZARATO, LORETTA; FRUTTERO, ROBERTA; CHUNG, MAN CHIN; PAVAN, FERNANDO ROGERIO; DOS SANTOS, JEAN LEANDRO. Synthesis and biological activity of furoxan derivatives against Mycobacterium tuberculosis. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, v. 123, p. 523-531, NOV 10 2016. Web of Science Citations: 23. (13/14957-5, 14/24811-0, 14/11586-9, 14/02240-1)
DE GRANDIS, RONE A.; DE CAMARGO, MARIANA S.; DA SILVA, MONIZE M.; LOPES, ERICA O.; PADILHA, ELIAS C.; RESENDE, FLAVIA A.; PECCININI, ROSANGELA G.; PAVAN, FERNANDO R.; DESIDERI, ALESSANDRO; BATISTA, ALZIR A.; et al. Human topoisomerase inhibition and DNA/BSA binding of Ru(II)-SCAR complexes as potential anticancer candidates for oral application. BIOMETALS, v. 30, n. 3, p. 321-334, JUN 2017. Web of Science Citations: 7. (12/22364-1, 13/20078-4)
PLUTIN, ANA M.; ALVAREZ, ANISLAY; MOCELO, RAUL; RAMOS, RAUL; CASTELLANO, EDUARDO E.; DA SILVA, MONIZE M.; COLINA-VEGAS, LEGNA; PAVAN, FERNANDO R.; BATISTA, ALZIR A.. Anti-Mycobacterium tuberculosis activity of platinum(II)/N,N-disubstituted-N `-acyl thiourea complexes. Inorganic Chemistry Communications, v. 63, p. 74-80, JAN 2016. Web of Science Citations: 15. (13/14957-5, 14/13691-4)
GARCIA DE CARVALHO, NATALIA FERNANDES; SATO, DAISY NAKAMURA; PAVAN, FERNANDO R.; FERRAZOLI, LUCILAINE; CHIMARA, ERICA. Resazurin Microtiter Assay for Clarithromycin Susceptibility Testing of Clinical Isolates of Mycobacterium abscessus Group. JOURNAL OF CLINICAL LABORATORY ANALYSIS, v. 30, n. 5, p. 751-755, SEP 2016. Web of Science Citations: 8. (13/14957-5)
DA SILVA, PATRICIA B.; DE SOUZA, PAULA C.; FIORAMONTI CALIXTO, GIOVANA MARIA; LOPES, ERICA DE O.; FREM, REGINA C. G.; NETTO, ADELINO V. G.; MAURO, ANTONIO E.; PAVAN, FERNANDO R.; CHORILLI, MARLUS. In Vitro Activity of Copper(II) Complexes, Loaded or Unloaded into a Nanostructured Lipid System, against Mycobacterium tuberculosis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, v. 17, n. 5, MAY 2016. Web of Science Citations: 1. (13/14957-5, 13/09265-7)
PAVAN, FERNANDO R.; POELHSITZ, GUSTAVO V.; DA CUNHA, LUCAS V. P.; BARBOSA, MARILIA I. F.; LEITE, SERGIO R. A.; BATISTA, ALZIR A.; CHO, SANG H.; FRANZBLAU, SCOTT G.; DE CAMARGO, MARIANA S.; RESENDE, FLAVIA A.; et al. In Vitro and In Vivo Activities of Ruthenium(II) Phosphine/Diimine/Picolinate Complexes (SCAR) against Mycobacterium tuberculosis. PLoS One, v. 8, n. 5, MAY 28 2013. Web of Science Citations: 27. (09/06499-1, 11/11593-7)
PAVAN, FERNANDO R.; MAIA, PEDRO I. DA S.; LEITE, SERGIO R. A.; DEFLON, VICTOR M.; BATISTA, ALZIR A.; SATO, DAISY N.; FRANZBLAU, SCOTT G.; LEITE, CLARICE Q. F.. Thiosemicarbazones, semicarbazones, dithiocarbazates and hydrazide/hydrazones: Anti-Mycobacterium tuberculosis activity and cytotoxicity. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, v. 45, n. 5, p. 1898-1905, MAY 2010. Web of Science Citations: 168. (08/10390-2)
COELHO, ROBERTA GOMES; HONDA, NELI KIKA; VIEIRA, MARIA DO CARMO; BRUM, ROSENEI LOUZADA; PAVAN, FERNANDO ROGERIO; FUJIMURA LEITE, CLARICE QUEICO; LIMA CARDOSO, CLAUDIA ANDREA. Chemical Composition and Antioxidant and Antimycobacterial Activities of Bromelia balansae (Bromeliaceae). JOURNAL OF MEDICINAL FOOD, v. 13, n. 5, p. 1277-1280, OCT 2010. Web of Science Citations: 6. (08/10390-2)
PAVAN, FERNANDO R.; POELHSITZ, GUSTAVO V.; BARBOSA, MARILIA I. F.; LEITE, SERGIO R. A.; BATISTA, ALZIR A.; ELLENA, JAVIER; SATO, LETICIA S.; FRANZBLAU, SCOTT G.; MORENO, VIRTUDES; GAMBINO, DINORAH; et al. Ruthenium(II) phosphine/diimine/picolinate complexes: Inorganic compounds as agents against tuberculosis. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, v. 46, n. 10, p. 5099-5107, OCT 2011. Web of Science Citations: 53. (08/10390-2)
MIYATA, MARCELO; PAVAN, FERNANDO ROGERIO; SATO, DAISY NAKAMURA; MARINO, LEONARDO BIANCOLINO; HIRATA, MARIO HIROYUKI; CARDOSO, ROSILENE FRESSATI; FIUZA DE MELO, FERNANDO AUGUSTO; ZANELLI, CLESLEI FERNANDO; FUJIMURA LEITE, CLARICE QUEICO. Drug resistance in Mycobacterium tuberculosis clinical isolates from Brazil: Phenotypic and genotypic methods. BIOMEDICINE & PHARMACOTHERAPY, v. 65, n. 6, p. 456-459, SEP 2011. Web of Science Citations: 12. (08/10390-2)
CARMO, ARTURENE M. L.; SILVA, FLAVIA M. C.; MACHADO, PATRICIA A.; FONTES, ANA P. S.; PAVAN, FERNANDO R.; LEITE, CLARICE Q. F.; LEITE, SERGIO R. DE A.; COIMBRA, ELAINE S.; DA SILVA, ADILSON D.. Synthesis of 4-aminoquinoline analogues and their platinum(II) complexes as new antileishmanial and antitubercular agents. BIOMEDICINE & PHARMACOTHERAPY, v. 65, n. 3, p. 204-209, JUN 2011. Web of Science Citations: 32. (08/10390-2)
LARROUY-MAUMUS, GERALD; MARINO, LEONARDO B.; MADDURI, ASHOKA V. R.; RAGAN, T. J.; HUNT, DEBBIE M.; BASSANO, LUCREZIA; GUTIERREZ, MAXIMILIANO G.; MOODY, D. BRANCH; PAVAN, FERNANDO R.; DE CARVALHO, LUIZ PEDRO S.. Cell-Envelope Remodeling as a Determinant of Phenotypic Antibacterial Tolerance in Mycobacterium tuberculosis. ACS INFECTIOUS DISEASES, v. 2, n. 5, p. 352-360, MAY 2016. Web of Science Citations: 7. (13/14957-5, 11/21232-1)
DA SILVA, PATRICIA B.; BONIFACIO, BRUNA V.; FREM, REGINA C. G.; GODOY NETTO, ADELINO V.; MAURO, ANTONIO E.; DA COSTA FERREIRA, ANA M.; LOPES, ERICA DE O.; RADDI, MARIA S. G.; BAUAB, TAIS M.; PAVAN, FERNANDO R.; et al. A Nanostructured Lipid System as a Strategy to Improve the in Vitro Antibacterial Activity of Copper(II) Complexes. Molecules, v. 20, n. 12, p. 22534-22545, DEC 2015. Web of Science Citations: 6. (13/14957-5, 13/09265-7)